Escherichia coli msbB gene as a virulence factor and a therapeutic target

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6583-6590

  Somerville Jr , John E ^b   Cassiano, Linda ^b   Darveau, Richard P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; ESCHERICHIA COLI LIPOPOLYSACCHARIDE;

ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; COMPLEMENT DEPOSITION; ESCHERICHIA COLI; GENE MUTATION; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL;

ACYLTRANSFERASES; ANIMALS; BACTERIAL CAPSULES; COMPLEMENT C3; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; LIPID A; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MUTAGENESIS; OPSONIN PROTEINS; PHAGOCYTOSIS; VIRULENCE;

EID: 0032728550     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Baker, P. J., T. Hraba, C. E. Taylor, P. W. Stashak, M. B. Fauntleroy, U. Zahringer, K. Takayama, T. R. Sievert, X. Hronowski, R. J. Cotter, and G. Perez-Perez. 1994. Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides. Infect. Immun. 62:2257-2269.
2. Bolivar, F., R. L. Rodriguez, P. J. Greene, M. C. Betlach, H. L. Heyneker, and H. W. Boyer. 1977. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2:95-113.
3. Bucklin, S. E., and D. C. Morrison. 1996. Bacteremia versus endotoxemia in experimental mouse leukopenia - role of antibiotic chemotherapy. J. Infect. Dis. 174:1249-1254.
4. Clementz, T., J. Bednarski, and C. R. H. Raetz. 1995. Escherichia coli genes encoding KDO dependent acyltransferases that incorporate laurate and myristate into lipid A. FASEB J. 9:A1311. (Abstract.)
5. Cross, A., L. Asher, M. Seguin, L. Yuan, N. Kelly, C. Hammack, J. Sadoff, and P. Gemski. 1995. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J. Clin. Investig. 96:676-686.
6. Cross, A. S., P. Gemski, J. C. Sadoff, F. Ørskov, and I. Ørskov. 1984. The importance of the K1 capsule in invasive infections caused by Escherichia coli. J. Infect. Dis. 149:184-193.
7. Darveau, R. P., M. D. Cunningham, T. Bailey, C. Seachord, K. Ratcliffe, B. Bainbridge, M. Dietsch, R. C. Page, and A. Aruffo. 1995. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect. Immun. 63:1311-1317.
8. Delude, R. L., R. Savedra, Jr., H. Zhao, R. Thieringer, S. Yamamoto, M. J. Fenton, and D. T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92:9288-9292.
9. Galanos, C., O. Luderitz, E. T. Rietschel, O. Westphal, H. Brade, L. Brade, M. Freudenberg, U. Schade, M. Imoto, H. Yoshimura, S. Kusumoto, and T. Shiba. 1985. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148:1-5.
10. Hammond, S. M. 1992. Inhibitors of lipopolysaccharide biosynthesis impair the virulence potential of Escherichia coli. FEMS Microbiol. Lett. 100:293-298.
11. Karow, M., and C. Georgopoulos. 1992 Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature-requirement gene htrB. J. Bacteriol. 174:702-710.
12. Khan, S. A., P. Everest, S. Servos, N. Foxwell, U. Zähringer, H. Brade, E. T. Rietschel, G. Dougan, I. G. Charles, and D. J. Maskell. 1998. A lethal role for lipid A in Salmonella infections. Mol. Microbiol. 29:571-579.
13. Koch, A. L. 1981. Growth measurement: colony counts, p. 185-188. In P. Gerhardt, R. G. E. Murray, R. N. Costilow, E. W. Nester, W. A. Wood, N. R. Krieg, and G. B. Phillips (ed.), Manual of methods for general bacteriology. American Society for Microbiology, Washington, D.C.
14. Leying, H., S. Suerbaum, H.-P. Kroll, D. Stahl, and W. Opferkuch. 1990. The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Infect. Immun. 58:222-227.
15. MacLachlan, P. R., W. J. Keenleyside, C. Dodgson, and C. Whitfield. 1993. Formation of the K30 (group 1) capsule in Escherichia coli O9:K30 does not require attachment to lipopolysaccharide lipid A-core. J. Bacteriol. 175: 7515-7522.
16. Mahenthiralingam, E., and D. P. Speert. 1995. Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum. Infect. Immun. 63: 4519-4523.
17. Miller, J. H. 1992. A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria, p. 268-274. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
18. Nichols, W. A., C. R. H. Raetz, T. Clementz, A. L. Smith, J. A. Hanson, M. R. Ketterer, et al. 1997. htrB of Haemophilus influenzae: determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity. J. Endotoxin Res. 4:163-172.
19. Ogawa, T., H. Uchida, and K. Amino. 1994. Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphymmonas gingivalis. Microbiology 140:1209-1216.
20. Ohno, A., Y. Isii, K. Tateda, T. Matumoto, S. Miyazaki, S. Yokota, and K. Yamaguchi. 1995. Role of LPS length in clearance rate of bacteria from the bloodstream in mice. Microbiology 141:2749-2756.
21. Onishi, H. R., B. A. Pelak, L. S. Gerckens, L. L. Silver, F. M. Kahan, M.-H. Chen, A. A. Patchett, S. M. Galloway, S. A. Hyland, M. S. Anderson, and C. R. H. Raetz. 1996. Antibacterial agents that inhibit lipid A biosynthesis. Science 274:980-982.
22. Pier, G. B., M. Grout, T. S. Zaidi, J. C. Olsen, L. G. Johnson, J. R. Yankaskas, and J. B. Goldberg. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271:64-67.
23. Prentki, P., and H. M. Krisch. 1984. In vitro insertional mutagenesis wilh a selectable DNA fragment. Gene 29:303-313.
24. Raetz, C. R. H. 1993. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J. Bacteriol. 175:5745-5753.
25. Raetz, C. R. H. 1996. Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles, p. 1035-1063. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, D.C.
26. Raff, H. V., D. Devereux, W. Shuford, D. Abbolt-Brown, and G. Maloney. 1988. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neiseria meningitidis group B infections. J. Infect. Dis. 157:118-126.
27. Reife, R. A., R. A. Shapiro, B. A. Bamber, K. K. Berry, G. E. Mick, and R. P. Darveau. 1995. Porphymmonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation. Infect. Immun. 63:4686-4694.
28. Rietschel, E. T., T. Kirkae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zähringer, U. Seydel, F. D. Padova, M. Schreier, and H. Brade. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217-225.
29. Rudbach, J. A., D. S. Keegan, and C. G. Sowell. 1995. Calculating therapeutic indices and therapeutic advantages for endotoxins and monophosphoral lipid A: an evaluation of data from the scientific literature. J. Endotoxin Res. 2:301-310.
30. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y.
31. Schwartz, H., and J. L. Whitton. 1992. A rapid, inexpensive method for eluting DNA from agarose or acrylamide gel slices without using toxic or chaotropic materials. BioTechniques 13:205-206.
32. Slater, S., and R. Maurer. 1993. Simple phagemid-based system for generating allele replacements in Escherichia coli. J. Bacteriol. 175:4260-4262.
33. Somerville, J. E., Jr., L. Cassiano, B. Bainbridge, M. D. Cunningham, and R. P. Darveau. 1996. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J. Clin. Investig. 97:359-365.
34. Takada, H., and S. Kotani. 1992. Structure-function relationships of lipid A, p. 107-130. In D. C. Morrison and J. L. Ryan (ed.), Bacterial endotoxic lipopolysaccharides, vol. I. Molecular biochemistry and cellular biology. CRC Press, Inc., Boca Raton, Fla.
35. Underwood, K., K. Sjöstrom, R. Darveau, R. Lamont, H. Schenkein, J. Gunsolley, R. Page, and D. Engel. 1993. Serum antibody opsonic activity against Actinobacillus actinomycetemcomitans in human periodontal diseases. J. Infect. Dis. 168:1436-1443.
36. van Putten, J. P. M. 1993. Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae. EMBO J. 12:4043-4051.
37. Vogel, S. N., and M. M. Hogan. 1990. Role of cytokines in endotoxin-mediated host responses, p. 238-252. In J. J. Oppenheim and E. M. Shevach (ed.), Immunophysiology: the role of cells and cytokines in immunity and inflammation. Oxford University Press, Oxford, England.
38. Vuorio, R., and M. Vaara. 1995. Comparison of the phenotypes of the lpxA and lpxD mutants of Escherichia coli. FEMS Microbiol. Lett. 134:227-232.
39. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.